The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals

AIDS

Volumn 14, Issue 16, 2000, Pages 2437-2443

  Lawn, Stephen D ^a   Karanja, Diana M S ^b   Mwinzi, Pauline ^b   Andove, Julius ^b   Colley, Daniel G ^c   Folks, Thomas M ^c   Secor, W Evan ^c  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Africa; Coinfections; HIV 1; Immune activation; Plasma HIV load; Praziquantel; Schistosomiasis

Indexed keywords

CD4 ANTIGEN; PRAZIQUANTEL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; KENYA; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; ANIMALS; ANTHELMINTICS; ANTIGENS, HELMINTH; FECES; HIV INFECTIONS; HIV-1; HUMANS; MALE; PARASITE EGG COUNT; PRAZIQUANTEL; RNA, VIRAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 0033730188     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200011100-00004     Document Type: Article

References (40)

1. Reduced rate of disease development after HIV-2 infection compared to HIV-1
2. Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection
3. Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients
4. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
5. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
6. Immune correlates of protection from HIV and AIDS - More answers but yet more questions
7. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
8. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1
9. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
10. The effect of acute infectious illnesses on plasma human immunodeficiency virus type I load and the expression of serologic markers of immune activation among HIV-infected adults
11. Accelerated course of HIV infection after tuberculosis
12. A Th1 to Th2 switch is a critical step in the etiology of HIV infection
13. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells
14. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals
15. Natural history and spectrum of disease in adults with HIV/AIDS in Africa
16. Immunological activation markers in the serum of African and European HIV-positive and seronegative individuals
17. Raised levels of tumour necrosis factoralpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia
18. Immune dysregulation in Ethiopian immigrants in Israel: Relevance to helminth infections?
19. Immune activation is a dominant factor in the pathogenesis of African AIDS
20. Influence of microbial infections on the progression of HIV disease
21. Can eradication of helminthic infections change the face of AIDS and tuberculosis?
22. Schistosomiasis
23. Down-regulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni
24. Leukocytes of patients with Schistosoma mansoni respond with a Th2 patters of cytokine production to mitogen or egg antigens but with a Th0 patters to worm antigens
25. Infection with Schistosoma mansoni infection alters Th1/Th2 cytokine responses to a non-parasite antigen
26. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni
27. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell responses as well as delayed virus clearance
28. Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections
29. Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1
30. Diagnosis of human schistosomiasis by detection of circulating cathodic antigen with a monoclonal antibody
31. The anatomical basis of intestinal immunity
32. Increase in plasma viral load after oral cholera immunization of HIV infected subjects
33. Immunopathology of Schistosoma mansoni infection
34. Cellular compartments of human immunodeficiency virus type 1 replication in vivo: Determination by presence of virion-associated host proteins and impact of opportunistic infection
35. Sustained plasma TNF-α and HIV-1 load despite resolution of other immune activation parameters during treatment of tuberculosis in Africans
36. Correlation between HIV-1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix
37. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration
38. 6 cells/l
39. Course of viral load throughout HIV-1 infection
40. Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha